Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Registered Nurse, RN

Overview: Everett Center is now hiring RNs for NOC FT Shift (10 PM - 6 AM) with Rotating Weekends! At Genesis Healthcare, we are dedicated to improving the lives we touch through the delivery of high-quality care and exceptional service. As a leading provider in the long-term care industry, we believe in fostering a collaborative, inclusive and supportive work environment where every team member is valued and empowered to make a difference. Whether you're an experienced professional or just starting your career, we offer opportunities for growth, development, and advancement in a range of roles. Join us in our mission to enhance the well-being of our patients and residents while making a meaningful impact in the communities we serve. Responsibilities: Change the lives of our patients/residents and at the same time enjoy the rewards of fully knowing your patients/residents and their families as a Registered Nurse - RN. You will provide care for a variety of patients/residents with an array of complex diagnoses leading to enhanced knowledge and skills in many different areas. Position Highlights Perform nursing assessments and collaborate with the nursing team, other disciplines, patients, and families to develop effective plans of care. Establish realistic, measurable short- and long-term patient goals with interventions put in place as needs arise to minimize rehospitalizations and continued evaluation of outcomes. Administer medications and performs treatments per physician orders. Delegate patient care responsibilities to staff and supervise them to ensure that tasks and interventions are implemented. Communicate patient information with assigned staff and between shifts. Qualifications: Must be a graduate of an approved school of nursing and currently licensed by the State Board of Nursing CPR Certification is required Benefits: Variable compensation plans Tuition, Travel, and Wireless Service Discounts Employee Assistance Program to support mental health Employee Foundation to financially assist through unforeseen hardships Health, Dental, Vision, Company-paid life insurance, 401K, Paid Time Off Free 24/7 virtual health care provided by licensed doctors for all Anthem medically-enrolled employees and their immediate family members On-Demand Pay Program that allows for instant access to a portion of the money you've already earned We also offer several voluntary insurances such as: Pet Insurance Term and Whole Life Insurance Short-term Disability Hospital Indemnity Personal Accident Critical Illness Cancer Coverage Restrictions apply based on collective bargaining agreements, applicable state law and factors such as pay classification, job grade, location, and length of service. Posted Salary Range: USD $50.00 - USD $54.00 /Hr.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology? The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office. This is a hybrid position and is onsite three days a week. Position Description Summary Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area. You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. Main Responsibilities & Accountabilities Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. Qualifications & Experience Requirements 15 years in biopharma with significant experience in clinical development, external innovation, or business development. Advanced degree required (MD, PhD, or equivalent). Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas. Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. Strong understanding of regulatory pathways, market access, and competitive standards of care. The expected base salary range for this position at hiring is $263,000 - $328,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed for Waltham MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.